Show results for
Refine by
Autoimmunity Treatment Equipment & Supplies In Latvia
19 equipment items found
Manufactured by:MEDICA S.P.A. based inMedolla, ITALY
Leukocyte Adsorber LA25: cartridge for selective leukocyte adsorption in the treatment of autoimmune diseases such as Crohn's disease and drug-unresponsiveulcerative rectocolitis. The cartridge uses a proprietary adsorption technology based on MediSulfone®. ...
Manufactured by:Octapharma AG based inLachen, SWITZERLAND
octagam® 5% (50 mg/ml), Human Normal Immunoglobulin. octagam® 10% (100 mg/ml), Human Normal Immunoglobulin. Liquid, ready-to-use intravenous immunoglobulin ...
Manufactured by:Octapharma AG based inLachen, SWITZERLAND
Indication: To treat patients that require replacement of antibodies to help provide protection against some infections. For treatment of some autoimmune disorders (diseases where the immune system is overactive). Panzyga® can only be obtained on a doctor’s ...
Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA
The Company's first product indicated for the treatment of autoimmune diseases. (adalimumab injection) was approved by the NMPA in December 2020. It is indicated for rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis and uveitis. It is the first China-developed adalimumab biosimilar that is manufactured in a China and Europe GMP certificated ...
Manufactured by:Cerbios-Pharma SA based inBarbengo – Lugano, SWITZERLAND
It is the most active known form of Vitamin D3 in stimulating intestinal calcium transport and is highly potent (category 4 SafeBridge). It is also recommended in therapies for the treatment of some autoimmune diseases and certain cancer types (with strict dosage ...
Manufactured by:Diamyd Medical AB based inStockholm, SWEDEN
Remygen® is a controlled release tablet consisting of the active pharmaceutical ingredient GABA. The GABA substance is chemically synthesized in a well-controlled GMP process together with a global contract manufacturer. The manufacturing process is scalable and pediatric formulations with the same properties can be designed. ...
Manufactured by:Creative Diagnostics based inShirley, NEW YORK (USA)
When performed according to these instructions, the results of this autoantibody profile may aid in the diagnosis and treatment of autoimmune connective tissue disorders. ...
Manufactured by:Biotest AG based inDreieich, GERMANY
IgG Next Generation is a new development of a polyvalent immungiobulin (NIG) for the treatment of immunedeficiencies and auto immune diseases. IgG Next Generation is manufactured with a new and innovative production process and will be the main product of the new manufacturing site Biotest Next ...
Manufactured by:Biotest AG based inDreieich, GERMANY
IgG Next Generation is a new development of a polyvalent immunglobulin (IVIG) for the treatment of immunedeficiencies and auto immune diseases. IgG Next Generation is being manufactured with a new and innovative production process and will be the main product of the new manufacturing site Biotest Next ...
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
Oncimmune’s proprietary biomarker discovery engine, which is leveraged in our ImmunoINSIGHTS services to discover and validate novel biomarkers that can help stratify patients in multiple cancer indications and with different autoimmune ...
Manufactured by:Bio-Techne based inMinneapolis, MINNESOTA (USA)
Immune cell therapy is rapidly emerging as an important alternative for cancer treatment, as well as treatment of autoimmune disease. Also known as adoptive cell therapy or cellular immunotherapy, it supercharges an individual’s immune cells to fight disease. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Pamapimod has no activity against p38δ or p38γ isoforms. Pamapimod has the potential for rheumatoid arthritis and other autoimmune diseases ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Enpatoran (M5049) is a potent, orally active and dual TLR7/8 inhibitor with IC50s of 11.1 nM and 24.1 nM in HEK293 cells, respectively. Enpatoran is inactive against TLR3, TLR4 and TLR9. Enpatoran can block molecule synthetic ligands and natural endogenous RNA ligands. Enpatoran exhibits excellent pharmacokinetic properties in vivo. Enpatoran can be used for both innate and adaptive autoimmunity ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Frexalimab (SAR441344) is a second-generation monoclonal antibody targeting the CD40 ligand (CD40L) with a good safety profile. Frexalimab inhibits the binding between CD40 and CD40L to modulate immune response. Frexalimab is likely to help prevent the process of β-cell destruction. Frexalimab is proming for multiple sclerosis, lupus erythematosus, Sjögren’s syndrome and type I diabetes ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
AX-024 is an orally available, first-in-class inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 ~1 nM. AX-024 modulates cell signaling by targeting SH3 domains. AX-024 has low-acute toxicity and high potency and selectivity, and strongly inhibit the production of IL-6, TNF-α, IFN-γ, IL-10 and ...
Manufactured by:Toleris Biotherapeutics GmbH based inWürzburg, GERMANY
AIM Bio has developed a platform of Autoimmunity Modifying Biologicals (AIM Biologicals) that uses soluble, near-physiological proteins to induce selective, antigen-specific immune tolerance. These proteins mimic a natural process observed in pregnancy that protects the embryo from the maternal immune system. By leveraging optimized soluble versions of the non-classical MHC Ib molecule HLA-G, AIM ...
by:CuraVac Europe S.A. based inRixensart, BELGIUM
The MYASTERIX project (2013 – 2018) advanced a Therapeutic Vaccine candidate (designated orphan drug) indicated for myasthenia gravis (MG) to clinical proof of concept ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Deucravacitinib (BMS-986165) is a highly selective, orally bioavailable allosteric TYK2 inhibitor for the treatment of autoimmune diseases, which selectively binds to TYK2 pseudokinase (JH2) domain (IC50=1.0 nM) and blocks receptor-mediated Tyk2 activation by stabilizing the regulatory JH2 domain. Deucravacitinib inhibits IL-12/23 and type I IFN pathways. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
ERG240 is an oral active branched-chain amino acid aminotransferase 1 (BCAT1) inhibitor. ERG240 can be used for the research of cancer, rheumatoid arthritis, and bone ...